| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 1247 |
| 1 | CERTOLIZUMAB PEGOL | 471 |
| 2 | ERGOCALCIFEROL | 398 |
| 3 | ACETAMINOPHEN | 397 |
| 4 | POMALIDOMIDE | 378 |
| 5 | SECUKINUMAB | 370 |
| 6 | RUXOLITINIB | 366 |
| 7 | ASPIRIN | 319 |
| 8 | ASPIRIN 325 MG | 312 |
| 9 | ASPIRIN 81 MG | 312 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 118 | 0.0342 |
| 1 | BRODALUMAB | 55 | 0.0267 |
| 2 | ROPEGINTERFERON ALFA-2B | 36 | 0.0194 |
| 3 | MITAPIVAT | 25 | 0.0188 |
| 4 | MARIBAVIR | 43 | 0.0174 |
| 5 | LANADELUMAB-FLYO | 49 | 0.0152 |
| 6 | ETEPLIRSEN | 35 | 0.0145 |
| 7 | HUMAN IMMUNOGLOBULIN G | 294 | 0.0140 |
| 8 | ERGOCALCIFEROL | 398 | 0.0134 |
| 9 | VELAGLUCERASE ALFA | 26 | 0.0127 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 1612 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 747 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 712 |
| 3 | Corticosteroid [EPC] | 546 |
| 4 | Kinase Inhibitor [EPC] | 453 |
| 5 | Provitamin D2 Compound [EPC] | 398 |
| 6 | Interleukin-17A Antagonist [EPC] | 393 |
| 7 | Osmotic Laxative [EPC] | 350 |
| 8 | Janus Kinase Inhibitor [EPC] | 348 |
| 9 | Human Immunoglobulin G [EPC] | 338 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 42 | 0.0610 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 55 | 0.0267 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 56 | 0.0234 |
| 3 | Interferon alfa-2b [EPC] | 36 | 0.0194 |
| 4 | Pyruvate Kinase Activator [EPC] | 25 | 0.0188 |
| 5 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 43 | 0.0174 |
| 6 | Human Immunoglobulin G [EPC] | 338 | 0.0160 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 32 | 0.0154 |
| 8 | Provitamin D2 Compound [EPC] | 398 | 0.0134 |
| 9 | GLP-2 Analog [EPC] | 155 | 0.0115 |